ACTRN12620000724976
Completed
未知
Prolonged administration of Intravenous Medication through Midline compared to Standard peripheral intravenous cannula in children to reduce catheter failure.
Queenland Children's Hospital0 sites128 target enrollmentJuly 7, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hospitalised children requiring vascular access
- Sponsor
- Queenland Children's Hospital
- Enrollment
- 128
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Between 12 months and 18 years of age
- •2\. greater than 2\.5mm upper arm vein
- •3\. The treating team have indicated that the patient is expected to require 4 or more days of peripherally compatible intravenous therapy
- •4\. Informed consent to participate
- •5\. Require the insertion of a new intravenous access device
Exclusion Criteria
- •1\.Presence of a co\-existent central venous access device
- •2\.Non\-English speakers without an interpreter
- •3\.Children under care of department of communities or without a legal guardian
- •4\.Thrombosed vessels in the upper arm distal to the axillar
- •5\.Patient receiving end\-of\-life care
- •6\.Previous enrolment in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A phase II trial of long-term intravenous treatment with bi-weekly Azithromycin in patients with gastric lymphoma of the mucosa associated lymphoid tissue (MALT-lymphoma)gastric MALT LymphomaTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2020-003152-33-ATMed. Univ. Wien46
Completed
Phase 3
a clinical trial to find the most appropriate maintenance fluid in children with central nervous system infectioHealth Condition 1: null- to compare the incidence of hyponatremia with maintenance fluids ( isotonic and hypotonic) in children with CNS infectionsCTRI/2012/05/002637Kalawati Saran Chiuldrens Hospital90
Completed
Phase 2
Alternative therapy using continuous intravenous administration of adrenomedullin for patients with inflammatory bowel diseaseinflammatory bowel diseaseJPRN-UMIN000003230First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki10
Completed
Phase 1
Continuous intravenous adrenomedullin therapy for patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease)inflammatory bowel disease (ulcerative colitis and Crohn's disease)JPRN-UMIN000021421First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki10
Not yet recruiting
Not Applicable
Efficacy of Intravenous versus Intramuscular Injection of Tramadol for Sickle Cell Vaso-occlusive CrisisCTRI/2019/05/019359VIMSAR